Security key
377322102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 25,895,088
- Total 13F value
- $977,295,404
- Share change
- +2,146,182
- Put/Call ratio
- 0%
- SEC-reported price per share
- $37.74
- Number of holders
- 138
- Value change
- +$93,815,832
- Number of buys
- 106
- Number of sells
- 36
- Shares outstanding
- 58,134,728
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2016
Institutions
138
Top holders
10
GKOS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2016
Previous quarter: Q2 2016
GLAUKOS Corp SEC filings
GLAUKOS Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 377322102
Recent filing periods:
Ownership snapshot
Top reported holders of GKOS - GLAUKOS Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Jun 2016
13F
Lead comparable stake: 5%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
5%
Versant Venture Management, LLC
4.4%
Meritech Capital Associates III L...
4.4%
Capital World Investors
2.9%
LORD, ABBETT & CO. LLC
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
5%
|
$84,504,000
2,897,938 shares
|
— | 30 Jun 2016 |
| Versant Venture Management, LLC |
13F
Company
|
4.4%
|
$75,436,483
2,586,985 shares
|
— | 30 Jun 2016 |
| Meritech Capital Associates III L.L.C. |
13F
Company
|
4.4%
|
$75,019,000
2,572,651 shares
|
— | 30 Jun 2016 |
| Capital World Investors |
13F
Company
|
2.9%
|
$49,749,000
1,706,070 shares
|
— | 30 Jun 2016 |
| LORD, ABBETT & CO. LLC |
13F
Company
|
2.5%
|
$41,994,000
1,440,111 shares
|
— | 30 Jun 2016 |
| GILDER GAGNON HOWE & CO LLC |
13F
Company
|
2%
|
$33,296,000
1,141,840 shares
|
— | 30 Jun 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
138
Shares
25,895,088
Rows available
138
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
110
Q3 2016 holders
138
Holder diff
28
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 value | Q3 2016 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend